1 | greatest | 3,985 |
2 | inherent | 929 |
3 | attendant | 211 |
4 | steepest | 33 |
5 | sheer | 22 |
6 | hardest | 16 |
7 | undoubted | 14 |
8 | bmi-related | 9 |
9 | fullest | 9 |
10 | slightest | 9 |
11 | a-chain | 8 |
12 | hfcd-induced | 7 |
13 | immanent | 6 |
14 | glp-1-induced | 5 |
15 | crown/implant | 4 |
16 | e47k | 4 |
17 | peak/trough | 4 |
18 | anconeus | 3 |
19 | event-rate | 3 |
20 | ovoid/spheroid | 3 |
21 | pg201-mediated | 3 |
22 | redissolved | 3 |
23 | 17kda | 2 |
24 | 5'-amp-induced | 2 |
25 | acoustoelectric | 2 |
26 | apomorphine-evoked | 2 |
27 | asa-mediated | 2 |
28 | budongo | 2 |
29 | consolation | 2 |
30 | cts-induced | 2 |
31 | fibrate-mediated | 2 |
32 | gemfibrozil-associated | 2 |
33 | homoeologs | 2 |
34 | laity | 2 |
35 | load-specific | 2 |
36 | main-chain | 2 |
37 | peripartum-associated | 2 |
38 | pm-related | 2 |
39 | prt-induced | 2 |
40 | quin-induced | 2 |
41 | risk/ | 2 |
42 | self-compacted | 2 |
43 | stac-induced | 2 |
44 | stretching-induced | 2 |
45 | sympatho-inhibitory | 2 |
46 | torsadogenic | 2 |
47 | val-induced | 2 |
48 | β-ketoacyl | 2 |
49 | 'act | 1 |
50 | 15.9-month | 1 |
51 | 160-second | 1 |
52 | 2011-2017 | 1 |
53 | 3-mp-induced | 1 |
54 | 7.45-point | 1 |
55 | a2ar-mediated | 1 |
56 | abeta1-40-induced | 1 |
57 | ach-dependent | 1 |
58 | acv-induced | 1 |
59 | adhd-symptom | 1 |
60 | anf-induced | 1 |
61 | antiviral-induced | 1 |
62 | arsb-silencing-induced | 1 |
63 | barber-assisted | 1 |
64 | best-achievable | 1 |
65 | bicarbonate-induced | 1 |
66 | bmscs-induced | 1 |
67 | bond-order | 1 |
68 | buckypaper-density | 1 |
69 | cardiovasculoprotective | 1 |
70 | cb77-mediated | 1 |
71 | cegedim | 1 |
72 | clenbuterol-mediated | 1 |
73 | clofibrate-induced | 1 |
74 | coculture-induced | 1 |
75 | cognifit | 1 |
76 | colesevelam-induced | 1 |
77 | conventional/traditional | 1 |
78 | cost-based | 1 |
79 | cresct/infectious | 1 |
80 | cyr61-induced | 1 |
81 | dcr3-dependent | 1 |
82 | dht-mediated | 1 |
83 | discerning/heeding | 1 |
84 | drought-associated | 1 |
85 | duloxetine-specific | 1 |
86 | ecvd-risk | 1 |
87 | egf‑mediated | 1 |
88 | et-mediated | 1 |
89 | ethanol-evoked | 1 |
90 | exemestane-induced | 1 |
91 | experimental-firm | 1 |
92 | ezetimibe-induced | 1 |
93 | fenofibrate-mediated | 1 |
94 | ff-mediated | 1 |
95 | fkbp12-mediated | 1 |
96 | flaxseed-mediated | 1 |
97 | flx-induced | 1 |
98 | gabapentin-induced | 1 |
99 | giardia-associated | 1 |
100 | gough | 1 |
101 | grassroot | 1 |
102 | gywnns | 1 |
103 | happiest | 1 |
104 | hlcat-mediated | 1 |
105 | hydrochlorothiazide-associated | 1 |
106 | hyperaminoacidemia-hyperinsulinemia-induced | 1 |
107 | hypercapnic-induced | 1 |
108 | hypergravity-induced | 1 |
109 | il-32γ-mediated | 1 |
110 | intellect-sparing | 1 |
111 | ion-exchanging | 1 |
112 | kc-cm-induced | 1 |
113 | ketamine-group | 1 |
114 | khatena-torrance | 1 |
115 | last-known | 1 |
116 | leptin-mediated | 1 |
117 | leptin-reversible | 1 |
118 | listening-induced | 1 |
119 | ly-induced | 1 |
120 | m-dependence | 1 |
121 | main-lobe | 1 |
122 | maximum-fold | 1 |
123 | medium-long-term | 1 |
124 | minimimize | 1 |
125 | mir-152-mediated | 1 |
126 | mk-0773-induced | 1 |
127 | most-pronounced | 1 |
128 | motor-imagery-induced | 1 |
129 | n24 | 1 |
130 | n30 | 1 |
131 | nadph-linked | 1 |
132 | non-marketing | 1 |
133 | of.chd | 1 |
134 | omega-3-dependent | 1 |
135 | ondansetron-induced | 1 |
136 | oxazaborolidine-catalyzed | 1 |
137 | oxidant-stimulated | 1 |
138 | packing-mediated | 1 |
139 | pancreatitis-evoked | 1 |
140 | pasat-induced | 1 |
141 | pcm-associated | 1 |
142 | pde-3-induced | 1 |
143 | penodynamic | 1 |
144 | per-drink | 1 |
145 | personalist | 1 |
146 | ph≥9 | 1 |
147 | pitavastatin-induced | 1 |
148 | place-and-train | 1 |
149 | previously-observed | 1 |
150 | pulmonologist-rated | 1 |
151 | response-biasing | 1 |
152 | rvp1-mediated | 1 |
153 | sir-induced | 1 |
154 | sonomechanical | 1 |
155 | stalevo | 1 |
156 | stemi-mi | 1 |
157 | technical/surgical | 1 |
158 | telbivudine-induced | 1 |
159 | tempers | 1 |
160 | tgf-β1-dependent | 1 |
161 | third-decimal | 1 |
162 | tilt-associated | 1 |
163 | tiotropium-mediated | 1 |
164 | toque | 1 |
165 | trophotropic | 1 |
166 | tvd-patients | 1 |
167 | type-of-treatment | 1 |
168 | tyramine-induced | 1 |
169 | uc-induced | 1 |
170 | unsignificant | 1 |
171 | uv-dl-induced | 1 |
172 | vasopressin-associated | 1 |
173 | wbv-induced | 1 |
174 | weight-loss-associated | 1 |
175 | wja | 1 |
176 | wolf-kishner | 1 |
177 | xamoterol-mediated | 1 |
178 | zd1611-induced | 1 |
1 | 'act | 1 |
2 | 15.9-month | 1 |
3 | 160-second | 1 |
4 | 17kda | 2 |
5 | 2011-2017 | 1 |
6 | 3-mp-induced | 1 |
7 | 5'-amp-induced | 2 |
8 | 7.45-point | 1 |
9 | a-chain | 8 |
10 | a2ar-mediated | 1 |
11 | abeta1-40-induced | 1 |
12 | ach-dependent | 1 |
13 | acoustoelectric | 2 |
14 | acv-induced | 1 |
15 | adhd-symptom | 1 |
16 | anconeus | 3 |
17 | anf-induced | 1 |
18 | antiviral-induced | 1 |
19 | apomorphine-evoked | 2 |
20 | arsb-silencing-induced | 1 |
21 | asa-mediated | 2 |
22 | attendant | 211 |
23 | barber-assisted | 1 |
24 | best-achievable | 1 |
25 | bicarbonate-induced | 1 |
26 | bmi-related | 9 |
27 | bmscs-induced | 1 |
28 | bond-order | 1 |
29 | buckypaper-density | 1 |
30 | budongo | 2 |
31 | cardiovasculoprotective | 1 |
32 | cb77-mediated | 1 |
33 | cegedim | 1 |
34 | clenbuterol-mediated | 1 |
35 | clofibrate-induced | 1 |
36 | coculture-induced | 1 |
37 | cognifit | 1 |
38 | colesevelam-induced | 1 |
39 | consolation | 2 |
40 | conventional/traditional | 1 |
41 | cost-based | 1 |
42 | cresct/infectious | 1 |
43 | crown/implant | 4 |
44 | cts-induced | 2 |
45 | cyr61-induced | 1 |
46 | dcr3-dependent | 1 |
47 | dht-mediated | 1 |
48 | discerning/heeding | 1 |
49 | drought-associated | 1 |
50 | duloxetine-specific | 1 |
51 | e47k | 4 |
52 | ecvd-risk | 1 |
53 | egf‑mediated | 1 |
54 | et-mediated | 1 |
55 | ethanol-evoked | 1 |
56 | event-rate | 3 |
57 | exemestane-induced | 1 |
58 | experimental-firm | 1 |
59 | ezetimibe-induced | 1 |
60 | fenofibrate-mediated | 1 |
61 | ff-mediated | 1 |
62 | fibrate-mediated | 2 |
63 | fkbp12-mediated | 1 |
64 | flaxseed-mediated | 1 |
65 | flx-induced | 1 |
66 | fullest | 9 |
67 | gabapentin-induced | 1 |
68 | gemfibrozil-associated | 2 |
69 | giardia-associated | 1 |
70 | glp-1-induced | 5 |
71 | gough | 1 |
72 | grassroot | 1 |
73 | greatest | 3,985 |
74 | gywnns | 1 |
75 | happiest | 1 |
76 | hardest | 16 |
77 | hfcd-induced | 7 |
78 | hlcat-mediated | 1 |
79 | homoeologs | 2 |
80 | hydrochlorothiazide-associated | 1 |
81 | hyperaminoacidemia-hyperinsulinemia-induced | 1 |
82 | hypercapnic-induced | 1 |
83 | hypergravity-induced | 1 |
84 | il-32γ-mediated | 1 |
85 | immanent | 6 |
86 | inherent | 929 |
87 | intellect-sparing | 1 |
88 | ion-exchanging | 1 |
89 | kc-cm-induced | 1 |
90 | ketamine-group | 1 |
91 | khatena-torrance | 1 |
92 | laity | 2 |
93 | last-known | 1 |
94 | leptin-mediated | 1 |
95 | leptin-reversible | 1 |
96 | listening-induced | 1 |
97 | load-specific | 2 |
98 | ly-induced | 1 |
99 | m-dependence | 1 |
100 | main-chain | 2 |
101 | main-lobe | 1 |
102 | maximum-fold | 1 |
103 | medium-long-term | 1 |
104 | minimimize | 1 |
105 | mir-152-mediated | 1 |
106 | mk-0773-induced | 1 |
107 | most-pronounced | 1 |
108 | motor-imagery-induced | 1 |
109 | n24 | 1 |
110 | n30 | 1 |
111 | nadph-linked | 1 |
112 | non-marketing | 1 |
113 | of.chd | 1 |
114 | omega-3-dependent | 1 |
115 | ondansetron-induced | 1 |
116 | ovoid/spheroid | 3 |
117 | oxazaborolidine-catalyzed | 1 |
118 | oxidant-stimulated | 1 |
119 | packing-mediated | 1 |
120 | pancreatitis-evoked | 1 |
121 | pasat-induced | 1 |
122 | pcm-associated | 1 |
123 | pde-3-induced | 1 |
124 | peak/trough | 4 |
125 | penodynamic | 1 |
126 | per-drink | 1 |
127 | peripartum-associated | 2 |
128 | personalist | 1 |
129 | pg201-mediated | 3 |
130 | ph≥9 | 1 |
131 | pitavastatin-induced | 1 |
132 | place-and-train | 1 |
133 | pm-related | 2 |
134 | previously-observed | 1 |
135 | prt-induced | 2 |
136 | pulmonologist-rated | 1 |
137 | quin-induced | 2 |
138 | redissolved | 3 |
139 | response-biasing | 1 |
140 | risk/ | 2 |
141 | rvp1-mediated | 1 |
142 | self-compacted | 2 |
143 | sheer | 22 |
144 | sir-induced | 1 |
145 | slightest | 9 |
146 | sonomechanical | 1 |
147 | stac-induced | 2 |
148 | stalevo | 1 |
149 | steepest | 33 |
150 | stemi-mi | 1 |
151 | stretching-induced | 2 |
152 | sympatho-inhibitory | 2 |
153 | technical/surgical | 1 |
154 | telbivudine-induced | 1 |
155 | tempers | 1 |
156 | tgf-β1-dependent | 1 |
157 | third-decimal | 1 |
158 | tilt-associated | 1 |
159 | tiotropium-mediated | 1 |
160 | toque | 1 |
161 | torsadogenic | 2 |
162 | trophotropic | 1 |
163 | tvd-patients | 1 |
164 | type-of-treatment | 1 |
165 | tyramine-induced | 1 |
166 | uc-induced | 1 |
167 | undoubted | 14 |
168 | unsignificant | 1 |
169 | uv-dl-induced | 1 |
170 | val-induced | 2 |
171 | vasopressin-associated | 1 |
172 | wbv-induced | 1 |
173 | weight-loss-associated | 1 |
174 | wja | 1 |
175 | wolf-kishner | 1 |
176 | xamoterol-mediated | 1 |
177 | zd1611-induced | 1 |
178 | β-ketoacyl | 2 |
1 | risk/ | 2 |
2 | n30 | 1 |
3 | n24 | 1 |
4 | 2011-2017 | 1 |
5 | ph≥9 | 1 |
6 | 17kda | 2 |
7 | wja | 1 |
8 | load-specific | 2 |
9 | duloxetine-specific | 1 |
10 | penodynamic | 1 |
11 | torsadogenic | 2 |
12 | trophotropic | 1 |
13 | acoustoelectric | 2 |
14 | most-pronounced | 1 |
15 | abeta1-40-induced | 1 |
16 | glp-1-induced | 5 |
17 | zd1611-induced | 1 |
18 | cyr61-induced | 1 |
19 | pde-3-induced | 1 |
20 | mk-0773-induced | 1 |
21 | hyperaminoacidemia-hyperinsulinemia-induced | 1 |
22 | stac-induced | 2 |
23 | hypercapnic-induced | 1 |
24 | uc-induced | 1 |
25 | hfcd-induced | 7 |
26 | ezetimibe-induced | 1 |
27 | exemestane-induced | 1 |
28 | telbivudine-induced | 1 |
29 | tyramine-induced | 1 |
30 | coculture-induced | 1 |
31 | bicarbonate-induced | 1 |
32 | clofibrate-induced | 1 |
33 | anf-induced | 1 |
34 | arsb-silencing-induced | 1 |
35 | stretching-induced | 2 |
36 | listening-induced | 1 |
37 | antiviral-induced | 1 |
38 | val-induced | 2 |
39 | uv-dl-induced | 1 |
40 | colesevelam-induced | 1 |
41 | kc-cm-induced | 1 |
42 | pitavastatin-induced | 1 |
43 | gabapentin-induced | 1 |
44 | quin-induced | 2 |
45 | ondansetron-induced | 1 |
46 | 3-mp-induced | 1 |
47 | 5'-amp-induced | 2 |
48 | sir-induced | 1 |
49 | bmscs-induced | 1 |
50 | cts-induced | 2 |
51 | pasat-induced | 1 |
52 | prt-induced | 2 |
53 | wbv-induced | 1 |
54 | acv-induced | 1 |
55 | flx-induced | 1 |
56 | ly-induced | 1 |
57 | motor-imagery-induced | 1 |
58 | hypergravity-induced | 1 |
59 | nadph-linked | 1 |
60 | apomorphine-evoked | 2 |
61 | ethanol-evoked | 1 |
62 | pancreatitis-evoked | 1 |
63 | cost-based | 1 |
64 | giardia-associated | 1 |
65 | hydrochlorothiazide-associated | 1 |
66 | gemfibrozil-associated | 2 |
67 | pcm-associated | 1 |
68 | peripartum-associated | 2 |
69 | vasopressin-associated | 1 |
70 | weight-loss-associated | 1 |
71 | drought-associated | 1 |
72 | tilt-associated | 1 |
73 | pg201-mediated | 3 |
74 | rvp1-mediated | 1 |
75 | fkbp12-mediated | 1 |
76 | mir-152-mediated | 1 |
77 | cb77-mediated | 1 |
78 | asa-mediated | 2 |
79 | flaxseed-mediated | 1 |
80 | fibrate-mediated | 2 |
81 | fenofibrate-mediated | 1 |
82 | ff-mediated | 1 |
83 | packing-mediated | 1 |
84 | xamoterol-mediated | 1 |
85 | clenbuterol-mediated | 1 |
86 | tiotropium-mediated | 1 |
87 | leptin-mediated | 1 |
88 | a2ar-mediated | 1 |
89 | hlcat-mediated | 1 |
90 | et-mediated | 1 |
91 | dht-mediated | 1 |
92 | il-32γ-mediated | 1 |
93 | egf‑mediated | 1 |
94 | bmi-related | 9 |
95 | pm-related | 2 |
96 | oxidant-stimulated | 1 |
97 | pulmonologist-rated | 1 |
98 | undoubted | 14 |
99 | self-compacted | 2 |
100 | barber-assisted | 1 |
101 | redissolved | 3 |
102 | previously-observed | 1 |
103 | oxazaborolidine-catalyzed | 1 |
104 | of.chd | 1 |
105 | ovoid/spheroid | 3 |
106 | maximum-fold | 1 |
107 | 160-second | 1 |
108 | main-lobe | 1 |
109 | khatena-torrance | 1 |
110 | m-dependence | 1 |
111 | best-achievable | 1 |
112 | leptin-reversible | 1 |
113 | event-rate | 3 |
114 | toque | 1 |
115 | cardiovasculoprotective | 1 |
116 | minimimize | 1 |
117 | discerning/heeding | 1 |
118 | ion-exchanging | 1 |
119 | intellect-sparing | 1 |
120 | response-biasing | 1 |
121 | non-marketing | 1 |
122 | gough | 1 |
123 | peak/trough | 4 |
124 | 15.9-month | 1 |
125 | stemi-mi | 1 |
126 | e47k | 4 |
127 | per-drink | 1 |
128 | ecvd-risk | 1 |
129 | technical/surgical | 1 |
130 | sonomechanical | 1 |
131 | third-decimal | 1 |
132 | conventional/traditional | 1 |
133 | β-ketoacyl | 2 |
134 | cegedim | 1 |
135 | adhd-symptom | 1 |
136 | medium-long-term | 1 |
137 | experimental-firm | 1 |
138 | a-chain | 8 |
139 | main-chain | 2 |
140 | place-and-train | 1 |
141 | consolation | 2 |
142 | last-known | 1 |
143 | budongo | 2 |
144 | stalevo | 1 |
145 | ketamine-group | 1 |
146 | bond-order | 1 |
147 | sheer | 22 |
148 | wolf-kishner | 1 |
149 | homoeologs | 2 |
150 | gywnns | 1 |
151 | tempers | 1 |
152 | tvd-patients | 1 |
153 | anconeus | 3 |
154 | cresct/infectious | 1 |
155 | 'act | 1 |
156 | cognifit | 1 |
157 | unsignificant | 1 |
158 | attendant | 211 |
159 | crown/implant | 4 |
160 | tgf-β1-dependent | 1 |
161 | omega-3-dependent | 1 |
162 | dcr3-dependent | 1 |
163 | ach-dependent | 1 |
164 | type-of-treatment | 1 |
165 | immanent | 6 |
166 | inherent | 929 |
167 | 7.45-point | 1 |
168 | grassroot | 1 |
169 | hardest | 16 |
170 | happiest | 1 |
171 | fullest | 9 |
172 | steepest | 33 |
173 | greatest | 3,985 |
174 | slightest | 9 |
175 | personalist | 1 |
176 | sympatho-inhibitory | 2 |
177 | laity | 2 |
178 | buckypaper-density | 1 |